Cargando…
Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a progressive disease with symptoms that can have a major impact on patients’ physical health. The aim of this study was to evaluate quality of life (QoL), symptom severity and dyspnoea in COPD patients treated with aclidinium up to 24 we...
Autores principales: | Lange, Peter, Godtfredsen, Nina Skavlan, Olejnicka, Beata, Paradis, Bo-Anders, Curiac, Dan, Humerfelt, Sjur, Telg, Gunilla, Christensen, Helene Nordahl, Bitsch, Magnus Alexander, Andersen, Elisabeth Wreford, Bjermer, Leif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937723/ https://www.ncbi.nlm.nih.gov/pubmed/27387608 http://dx.doi.org/10.3402/ecrj.v3.31232 |
Ejemplares similares
-
Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
por: Contoli, Marco, et al.
Publicado: (2016) -
Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD
por: Karlsson, SL, et al.
Publicado: (2017) -
Interorganisational Integration: Healthcare Professionals’
Perspectives on Barriers and Facilitators within the Danish Healthcare
System
por: Lyngsø, Anne Marie, et al.
Publicado: (2016) -
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
por: Rivero-Ferrer, Elena, et al.
Publicado: (2022) -
Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids – a Swedish observational cohort study (PACEHR)
por: Janson, Christer, et al.
Publicado: (2018)